DBT vs Schema results
- A JAMA Psychiatry post reported that DBT and schema therapy produced similarly large improvements in outpatients with borderline personality disorder. - The two therapies showed comparable symptom reduction, functional gains, quality-of-life improvement, and similar retention rates. - These equivalent outcomes expand viable psychotherapy choices for outpatient BPD treatment planning. (x.com/JAMAPsych/status/2046984743430787420)
Borderline personality disorder is usually treated with long, structured talk therapy, and a new randomized trial found two leading options performed about the same over three years. (jamanetwork.com) The study, published online April 22, 2026, in *JAMA Psychiatry*, assigned 204 adults with borderline personality disorder at multiple outpatient centers to dialectical behavior therapy or schema therapy. (jamanetwork.com) Researchers reported that borderline personality disorder severity fell markedly across the full study period, with no statistically significant difference in effectiveness between the two treatments. (jamanetwork.com) Dialectical behavior therapy teaches patients skills for handling intense emotions, crises, and relationships, while schema therapy targets long-running patterns of beliefs and coping that often begin early in life. Both already had evidence behind them before this head-to-head trial. (jamanetwork.com) (pubmed.ncbi.nlm.nih.gov) The paper said the two groups also had comparable results on symptom reduction, psychosocial functioning, quality of life, and treatment retention, not just on the main severity measure. (jamanetwork.com) That matters for outpatient clinics because borderline personality disorder is linked to low quality of life, impaired functioning, and high societal costs, and programs often build around whichever therapy model they can staff and sustain. (pubmed.ncbi.nlm.nih.gov) Direct comparisons between these therapies have been rare. A 2024 report from the same randomized trial said dialectical behavior therapy and schema therapy were both effective for borderline personality disorder and found no overall winner. (pubmed.ncbi.nlm.nih.gov) Earlier research had already shown each approach could beat usual care or other comparators in separate studies. A 2022 *JAMA Psychiatry* trial found combined individual and group schema therapy outperformed optimal treatment as usual, while earlier trials established benefits for dialectical behavior therapy in suicidal behavior and borderline personality disorder. (jamanetwork.com 1) (jamanetwork.com 2) The new result does not end the search for differences between patients. A separate 2025 analysis based on the same trial reported that one subgroup appeared to benefit more from dialectical behavior therapy than schema therapy, even though the average results across all patients were similar. (pubmed.ncbi.nlm.nih.gov) For now, the clearest finding is narrower: in a three-year outpatient trial, both therapies delivered large gains, and neither proved broadly superior. (jamanetwork.com)
